Accessibility Links

Elliott Milton

Bio:
                    I graduated with a degree in Law from University of Aberdeen in 2013 and went on to join Phaidon International in 2013 at the opening of the Zurich office.
Starting as a specialist in the Finance & Accounting field at DSJ Global within Switzerland, I quickly took on further responsibilities leading the DSJ Global & EPM Scientific brands, and then furthermore taking on full leadership of the Zurich office as of November 2016.
Now overseeing the growth of the Zurich office into Europe's leading profit centre, I employ a tailored approach to all international clients that we currently work with, utilising the speed of a more conventional recruitment model, coupled with the more attentive approach to that of a Swiss-based recruitment framework.
                
Product Manager - Rx Austin
  • Job type: Permanent
  • Location: Austin
  • Salary: Competitive
  • Description Product Manager - Rx Austin 80,000 – 100,000$ A top 5 global pharmaceutical company are currently searching for a product management expert to oversee the expansion of their OTC & FMCG franchise...
Director of Strategy
  • Job type: Permanent
  • Location: Dallas
  • Salary: £150000 - £225000 per annum
  • Description EPM Scientific is currently working with one of the worlds most innovative biotech companies who have recently completed a multi-billion dollar merger and is looking to expand their global strategy team to ensure the...
Sales Representative Speciality Medicine
  • Job type: Permanent
  • Location: Dallas
  • Salary: Competitive
  • Description EPM Scientific is currently looking for a well-networked territory sales professional with experience across Immunology or Oncology. Our client is: - Overseeing the launch of a number of biosimilar products within...
Market Access Lead Oncology
  • Job type: Permanent
  • Location: Austin
  • Salary: Competitive
  • Description Market Access Lead Oncology 75,000 – 100,000$ EPM Scientific is seeking a Market Access Lead for a new Oncology product to recently receiving approval for US markets. Due to rapid growth...